Page last updated: 2024-10-28

lidocaine and Central Nervous System Diseases

lidocaine has been researched along with Central Nervous System Diseases in 22 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access."9.22Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. ( Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L, 2016)
"In this study, 8 patients with central pain syndromes, 6 with hemispheric lesions, and 2 with spinal cord lesions were treated with a 1 mg/kg dose of intravenous lidocaine."7.68Response of central pain syndromes to intravenous lidocaine. ( Backonja, M; Gombar, KA, 1992)
" Minor central nervous system side effects were seen in 2 patients and dermatologic adverse reaction was seen in one patient only."6.66Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study. ( Mahapatra, D; Mahapatra, RK, 1986)
"In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access."5.22Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. ( Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L, 2016)
"In this study, 8 patients with central pain syndromes, 6 with hemispheric lesions, and 2 with spinal cord lesions were treated with a 1 mg/kg dose of intravenous lidocaine."3.68Response of central pain syndromes to intravenous lidocaine. ( Backonja, M; Gombar, KA, 1992)
"In various chronic painful states, the sympathetic nerve supply was blocked either by injecting the sympathetic chain and ganglia with local anaesthesia or by the injection of guanethidine during occlusion of the circulation."3.66Painful peripheral states and sympathetic blocks. ( Loh, L; Nathan, PW, 1978)
"Lidocaine 2% was administered to eight dogs before surgery in differing amounts, depending on the volume of the joints involved, and blood samples were taken at predetermined time points."2.80Intra-articular administration of lidocaine in anaesthetized dogs: pharmacokinetic profile and safety on cardiovascular and nervous systems. ( Bufalari, A; Cagnardi, P; Catanzaro, A; De Monte, V; Della Rocca, G; Di Salvo, A; Marenzoni, ML; Vigorito, V, 2015)
" Minor central nervous system side effects were seen in 2 patients and dermatologic adverse reaction was seen in one patient only."2.66Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study. ( Mahapatra, D; Mahapatra, RK, 1986)
" We also observed animals for electrocardiographic evidence of toxic effects on cardiac automaticity, conductivity, and rhythmicity."1.37A comparison of the systemic toxicity of lidocaine versus its quaternary derivative QX-314 in mice. ( Cheung, HM; Lee, SM; MacLeod, BA; Ries, CR; Schwarz, SK, 2011)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-199013 (59.09)18.7374
1990's2 (9.09)18.2507
2000's2 (9.09)29.6817
2010's5 (22.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Salvo, A1
Bufalari, A1
De Monte, V1
Cagnardi, P1
Marenzoni, ML1
Catanzaro, A1
Vigorito, V1
Della Rocca, G1
Kudenchuk, PJ1
Brown, SP1
Daya, M1
Rea, T1
Nichol, G1
Morrison, LJ1
Leroux, B1
Vaillancourt, C1
Wittwer, L1
Callaway, CW1
Christenson, J1
Egan, D1
Ornato, JP1
Weisfeldt, ML1
Stiell, IG1
Idris, AH1
Aufderheide, TP1
Dunford, JV1
Colella, MR1
Vilke, GM1
Brienza, AM1
Desvigne-Nickens, P1
Gray, PC1
Gray, R1
Seals, N1
Straight, R1
Dorian, P1
Cheung, HM1
Lee, SM1
MacLeod, BA1
Ries, CR1
Schwarz, SK1
Sambrook, PJ1
Smith, W1
Elijah, J1
Goss, AN1
Lange, DB1
Schwartz, D1
DaRoza, G1
Gair, R1
Brosh-Nissimov, T1
Ingbir, M1
Weintal, I1
Fried, M1
Porat, R1
Bithal, PK1
Pandia, MP1
Chaturvedi, A1
Radhakrishnan, M1
Prabhakar, H1
Sharma, D1
Backonja, M1
Gombar, KA1
Selden, R1
Sasahara, AA1
Kalso, E1
Rosenberg, PH1
Bryant, CA1
Hoffman, JR1
Nichter, LS1
Bishop, D1
Johnstone, RE1
Loh, L1
Nathan, PW1
Mahapatra, RK1
Mahapatra, D1
Covino, BG1
Swan, HJ1
Bleifeld, W1
Merx, W1
Effert, S1
Harrison, DC1
Collinsworth, KA1
GueyƩ, SN1
Dosseh, B1
Geddes, IC1
Krenis, LJ1
Liu, PL1
Ngai, SH1
Coyas, A1
Bossinacou, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)[NCT01401647]Phase 33,024 participants (Actual)Interventional2012-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants Scoring at or Below a 3 on the MRS Scale

Neurologic status at discharge will be assessed using the modified Rankin Score (MRS). A higher value indicates a worse outcome. 0-No symptoms at all; 1-No significant disability despite symptoms; able to carry out all usual duties and activities, 2-Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3-Moderate disability; requiring some help, but able to walk without assistance; 4-Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5-Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6-Dead (NCT01401647)
Timeframe: Patients will be followed from the time of the cardiac arrest until death, hospital discharge, or December 31, 2015, whichever occurs first.

InterventionParticipants (Count of Participants)
Amiodarone182
Lidocaine172
Normal Saline175

Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge

Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital. (NCT01401647)
Timeframe: Patients will be followed from the time of the cardiac arrest until death, hospital discharge, or December 31, 2015, whichever occurs first.

Interventionparticipants (Number)
Amiodarone237
Lidocaine233
Normal Saline222

Reviews

3 reviews available for lidocaine and Central Nervous System Diseases

ArticleYear
Bupivacaine and intravenous regional anaesthesia--a matter of controversy.
    Annales chirurgiae et gynaecologiae, 1984, Volume: 73, Issue:3

    Topics: Anesthesia, Conduction; Anesthesia, Intravenous; Bupivacaine; Central Nervous System Diseases; Human

1984
Recent advances in local anaesthesia.
    Canadian Anaesthetists' Society journal, 1986, Volume: 33, Issue:3 Pt 2

    Topics: Acidosis; Anesthesia, Local; Anesthetics, Local; Animals; Arrhythmias, Cardiac; Bupivacaine; Cardiov

1986
Antiarrhythmic actions of lidocaine.
    Annual review of medicine, 1974, Volume: 25

    Topics: Action Potentials; Animals; Cell Membrane; Central Nervous System Diseases; Digitalis; Drug Interact

1974

Trials

4 trials available for lidocaine and Central Nervous System Diseases

ArticleYear
Intra-articular administration of lidocaine in anaesthetized dogs: pharmacokinetic profile and safety on cardiovascular and nervous systems.
    Journal of veterinary pharmacology and therapeutics, 2015, Volume: 38, Issue:4

    Topics: Anesthesia, General; Anesthetics, Local; Animals; Area Under Curve; Cardiovascular Diseases; Central

2015
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
    The New England journal of medicine, 2016, May-05, Volume: 374, Issue:18

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Central Nervous Syst

2016
Lidocaine infiltration of the scalp does not completely abolish increased intraocular pressure due to skull pin insertion.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:7

    Topics: Adult; Anesthetics, Local; Blood Pressure; Central Nervous System Diseases; Female; Heart Rate; Huma

2006
Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Angiology, 1986, Volume: 37, Issue:4

    Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Central Nervous Sy

1986

Other Studies

15 other studies available for lidocaine and Central Nervous System Diseases

ArticleYear
A comparison of the systemic toxicity of lidocaine versus its quaternary derivative QX-314 in mice.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2011, Volume: 58, Issue:5

    Topics: Anesthetics, Local; Animals; Central Nervous System Diseases; Dose-Response Relationship, Drug; Elec

2011
Severe adverse reactions to dental local anaesthetics: systemic reactions.
    Australian dental journal, 2011, Volume: 56, Issue:2

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anesthesia, Den

2011
Use of intravenous lipid emulsion to reverse central nervous system toxicity of an iatrogenic local anesthetic overdose in a patient on peritoneal dialysis.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:12

    Topics: Adult; Anesthetics, Local; Central Nervous System Diseases; Drug Overdose; Fat Emulsions, Intravenou

2012
Central nervous system toxicity following topical skin application of lidocaine.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:9

    Topics: Administration, Topical; Adult; Anesthetics, Local; Central Nervous System Diseases; Dose-Response R

2004
Response of central pain syndromes to intravenous lidocaine.
    Journal of pain and symptom management, 1992, Volume: 7, Issue:3

    Topics: Adult; Aged; Central Nervous System Diseases; Female; Humans; Injections, Intravenous; Lidocaine; Ma

1992
Central nervous system toxicity induced by lidocaine. Report of a case in a patient with liver disease.
    JAMA, 1967, Nov-27, Volume: 202, Issue:9

    Topics: Adult; Central Nervous System Diseases; Humans; Injections, Intravenous; Lidocaine; Liver Cirrhosis;

1967
Pitfalls and perils of intravenous lidocaine.
    The Western journal of medicine, 1983, Volume: 139, Issue:4

    Topics: Aged; Central Nervous System Diseases; Female; Humans; Injections, Intravenous; Lidocaine

1983
Lidocaine toxicity treated with low-dose propofol.
    Anesthesiology, 1993, Volume: 78, Issue:4

    Topics: Aged; Central Nervous System Diseases; Dose-Response Relationship, Drug; Endarterectomy, Carotid; Hu

1993
Painful peripheral states and sympathetic blocks.
    Journal of neurology, neurosurgery, and psychiatry, 1978, Volume: 41, Issue:7

    Topics: Anesthesia, Local; Bupivacaine; Central Nervous System Diseases; Differential Threshold; Female; Gua

1978
Cooperative study on cardiac catheterization. Complications involving the nervous system.
    Circulation, 1968, Volume: 37, Issue:5 Suppl

    Topics: Adolescent; Adult; Angiocardiography; Cardiac Catheterization; Central Nervous System Diseases; Chil

1968
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
    Deutsche medizinische Wochenschrift (1946), 1971, Apr-16, Volume: 96, Issue:16

    Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous Sys

1971
[Complications of local anesthesia using lignocaine].
    Bulletin de la Societe medicale d'Afrique noire de langue francaise, 1972, Volume: 17, Issue:2

    Topics: Adult; Anesthesia, Local; Central Nervous System Diseases; Child; Coma; Developing Countries; Female

1972
Local anaesthetics.
    Laval medical, 1971, Volume: 42, Issue:8

    Topics: Amides; Anesthetics, Local; Brain Edema; Cardiovascular Diseases; Central Nervous System Diseases; C

1971
The effect of local anesthetics on the central nervous system toxicity of hyperbaric oxygen.
    Neuropharmacology, 1971, Volume: 10, Issue:5

    Topics: Animals; Brain Chemistry; Central Nervous System Diseases; Cocaine; Dopamine; Hyperbaric Oxygenation

1971
Xylocaine and its effect on vertigo.
    The Journal of laryngology and otology, 1969, Volume: 83, Issue:7

    Topics: Ankylosis; Central Nervous System Diseases; Cervical Vertebrae; Humans; Lidocaine; Meniere Disease;

1969